These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [The importance of steroid and pituitary hormones in prostatic diseases. Discussion of a study]. Bouffioux C Acta Urol Belg; 1980 Oct; 48(4):445-51. PubMed ID: 6779514 [No Abstract] [Full Text] [Related]
4. [Advances in researches on the relationship between prostatic diseases and erectile dysfunction]. Zhan JC; Wei AY Zhonghua Nan Ke Xue; 2005 Jun; 11(6):462-5. PubMed ID: 15999496 [TBL] [Abstract][Full Text] [Related]
5. Testosterone levels in benign prostatic hyperplasia: sexual function and response to therapy with dutasteride. Swerdloff R Nat Clin Pract Urol; 2006 Oct; 3(10):528-9. PubMed ID: 17031376 [No Abstract] [Full Text] [Related]
6. [Relation between benign prostatic hyperplasia and obesity and estrogen]. Matsuda T; Abe H; Suda K Rinsho Byori; 2004 Apr; 52(4):291-4. PubMed ID: 15164594 [TBL] [Abstract][Full Text] [Related]
7. Measurements of prolactin and androgens in patients with prostatic disease. Saroff J; Kirdani RY; Chu TM; Wajsman Z; Murphy GP Surg Forum; 1977; 28():568-9. PubMed ID: 83009 [No Abstract] [Full Text] [Related]
8. Serum sodium and chloride in prostatic hypertrophy and cancer. Casey AE; Gilbert FE; Downey EL; Thomason S; Deacy JV Ala J Med Sci; 1970 Jan; 7(1):109-10. PubMed ID: 4193657 [No Abstract] [Full Text] [Related]
9. Testosterone levels in benign prostatic hypertrophy and prostate cancer. Mearini L; Costantini E; Zucchi A; Mearini E; Bini V; Cottini E; Porena M Urol Int; 2008; 80(2):134-40. PubMed ID: 18362481 [TBL] [Abstract][Full Text] [Related]
10. Testosterone metabolism in human prostatic tissue and blood in patients with benign prostatic hypertrophy (BPH). Becker H; Buric L; Petersen C; Voigt KD Acta Endocrinol Suppl (Copenh); 1971; 152():28. PubMed ID: 4101325 [No Abstract] [Full Text] [Related]
11. [Adrenal androgens and circulating 17 beta-estradiol/testosterone ratio in benign hyperplasia of the prostate]. Corrales Hernández JJ; García Díez LC; Martín Rodríguez M; Montero Gómez J; Miralles García JM Med Clin (Barc); 1984 May; 82(17):751-3. PubMed ID: 6204173 [No Abstract] [Full Text] [Related]
12. [Relations between red cell structure, function and immune homeostasis in prostatic diseases]. Shatokhin MN; Teodorovich OV; Konoplia AI; Dolgareva SA; Gavriliuk VP; Krasnov LV; Mavrin MIu Urologiia; 2012; (1):42-6. PubMed ID: 22646001 [TBL] [Abstract][Full Text] [Related]
14. Modifiable risk factors for benign prostatic hyperplasia and lower urinary tract symptoms: new approaches to old problems. Parsons JK J Urol; 2007 Aug; 178(2):395-401. PubMed ID: 17561143 [TBL] [Abstract][Full Text] [Related]
15. Body size and serum levels of insulin and leptin in relation to the risk of benign prostatic hyperplasia. Dahle SE; Chokkalingam AP; Gao YT; Deng J; Stanczyk FZ; Hsing AW J Urol; 2002 Aug; 168(2):599-604. PubMed ID: 12131317 [TBL] [Abstract][Full Text] [Related]
16. [Role of apoptosis and chronic prostatitis in the pathogenesis of benign prostatic hyperplasia]. Pawlicki B; Zieliński H; Dabrowski M Pol Merkur Lekarski; 2004 Oct; 17(100):307-10. PubMed ID: 15690689 [TBL] [Abstract][Full Text] [Related]
17. Benign prostatic hyperplasia due to venous drainage malfunction in the male reproductive system: a price of erect posture in humans. Schill WB; Ben-Shlomo I Andrologia; 2008 Oct; 40(5):272. PubMed ID: 18811915 [No Abstract] [Full Text] [Related]
18. [Impact of prostatic benign hyperplasia and prostatic inflammation on the increase of prostate specific antigen levels]. Ferrero Doria R; Pérez Flores D; Terrer Artes C; Guzmán Martínez-Valls PL; Morga Egea JP; Tomás Ros M; Rico Galiano JL; Sempere Gutiérrez A; Fontana Compiano LO Actas Urol Esp; 1997 Feb; 21(2):100-4. PubMed ID: 9214204 [TBL] [Abstract][Full Text] [Related]